123 related articles for article (PubMed ID: 2599056)
1. Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases.
Kapaki E; Segditsa J; Zournas C; Xenos D; Papageorgiou C
Experientia; 1989 Dec; 45(11-12):1108-10. PubMed ID: 2599056
[TBL] [Abstract][Full Text] [Related]
2. Lead in cerebrospinal fluid and its relationship to plasma lead in humans.
Cavalleri A; Minoia C; Ceroni M; Poloni M
J Appl Toxicol; 1984 Apr; 4(2):63-5. PubMed ID: 6736552
[TBL] [Abstract][Full Text] [Related]
3. Abnormal distribution of lead in amyotrophic lateral sclerosis--reestimation of lead in the cerebrospinal fluid.
Conradi S; Ronnevi LO; Nise G; Vesterberg O
J Neurol Sci; 1980 Dec; 48(3):413-8. PubMed ID: 7441289
[TBL] [Abstract][Full Text] [Related]
4. Norepinephrine and gamma-aminobutyric acid in amyotrophic lateral sclerosis.
Ziegler MG; Brooks BR; Lake CR; Wood JH; Enna SJ
Neurology; 1980 Jan; 30(1):98-101. PubMed ID: 7188643
[TBL] [Abstract][Full Text] [Related]
5. Decreased chloride levels of cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
Watanabe S; Kimura T; Suenaga K; Wada S; Tsuda K; Kasama S; Takaoka T; Kajiyama K; Takeda M; Yoshikawa H
J Neurol Sci; 2009 Oct; 285(1-2):146-8. PubMed ID: 19595376
[TBL] [Abstract][Full Text] [Related]
6. [Leukotrienes and neurological diseases].
Irkeç C; Ercan S; Irkeç M
Mikrobiyol Bul; 1989 Oct; 23(4):342-7. PubMed ID: 2488942
[TBL] [Abstract][Full Text] [Related]
7. Abnormal tissue distribution of lead in amyotrophic lateral sclerosis.
Conradi S; Ronnevi LO; Vesterberg O
J Neurol Sci; 1976 Oct; 29(2-4):259-65. PubMed ID: 978210
[TBL] [Abstract][Full Text] [Related]
8. [Total magnesium in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis].
Iłzecka J; Stelmasiak Z; Kot A
Neurol Neurochir Pol; 2000; 34(4):699-706. PubMed ID: 11105302
[TBL] [Abstract][Full Text] [Related]
9. Free insulin-like growth factor (IGF)-1 and IGF-binding proteins-2 and -3 in serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Corbo M; Lunetta C; Magni P; Dozio E; Ruscica M; Adobbati L; Silani V
Eur J Neurol; 2010 Mar; 17(3):398-404. PubMed ID: 19845745
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid "specific" proteins in various degenerative neurological diseases.
Wikkelsø C; Blomstrand C
Acta Neurol Scand; 1982 Aug; 66(2):199-208. PubMed ID: 6215816
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma levels of lead in patients with amyotrophic lateral sclerosis compared with control subjects as determined by flameless atomic absorption spectrophotometry.
Conradi S; Ronnevi LO; Vesterberg O
J Neurol Neurosurg Psychiatry; 1978 May; 41(5):389-93. PubMed ID: 77896
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid levels of alpha-tocopherol in amyotrophic lateral sclerosis.
de Bustos F; Jiménez-Jiménez FJ; Molina JA; Esteban J; Guerrero-Sola A; Zurdo M; Ortí-Pareja M; Tallón-Barranco A; Gómez-Escalonilla C; Ramírez-Ramos C; Arenas J; Enríquez de Salamanca R
J Neural Transm (Vienna); 1998; 105(6-7):703-8. PubMed ID: 9826112
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Zheng Y; Gao L; Wang D; Zang D
Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
[TBL] [Abstract][Full Text] [Related]
14. Amyotrophic lateral sclerosis: interleukin-6 levels in cerebrospinal fluid.
Krieger C; Perry TL; Ziltener HJ
Can J Neurol Sci; 1992 Aug; 19(3):357-9. PubMed ID: 1393846
[TBL] [Abstract][Full Text] [Related]
15. Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis.
Smith RG; Henry YK; Mattson MP; Appel SH
Ann Neurol; 1998 Oct; 44(4):696-9. PubMed ID: 9778272
[TBL] [Abstract][Full Text] [Related]
16. Amyotrophic lateral sclerosis.
Check WA
JAMA; 1979 Jul; 242(4):319. PubMed ID: 448927
[No Abstract] [Full Text] [Related]
17. Lead, cadmium and mercury in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: A case-control study.
Vinceti M; Filippini T; Mandrioli J; Violi F; Bargellini A; Weuve J; Fini N; Grill P; Michalke B
J Trace Elem Med Biol; 2017 Sep; 43():121-125. PubMed ID: 28089071
[TBL] [Abstract][Full Text] [Related]
18. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.
Mitchell RM; Freeman WM; Randazzo WT; Stephens HE; Beard JL; Simmons Z; Connor JR
Neurology; 2009 Jan; 72(1):14-9. PubMed ID: 18987350
[TBL] [Abstract][Full Text] [Related]
19. Cystatin C in cerebrospinal fluid as a biomarker of ALS.
Tsuji-Akimoto S; Yabe I; Niino M; Kikuchi S; Sasaki H
Neurosci Lett; 2009 Mar; 452(1):52-5. PubMed ID: 19444952
[TBL] [Abstract][Full Text] [Related]
20. Increased serum and cerebrospinal fluid FGF-2 levels in amyotrophic lateral sclerosis.
Johansson A; Larsson A; Nygren I; Blennow K; Askmark H
Neuroreport; 2003 Oct; 14(14):1867-9. PubMed ID: 14534437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
